{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:44:12Z","timestamp":1792500252593,"version":"4.5.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141657","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T19:18:49Z","timestamp":1446664729000},"page":"e0141657","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor"],"prefix":"10.1371","volume":"10","author":[{"given":"Saghir","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Chandrasekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreeja","family":"Attur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gursev S.","family":"Dhaunsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam H. M.","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim F.","family":"Benter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00109-014-1146-1","article-title":"The pathobiology of diabetic vascular complications-cardiovascular and kidney disease","volume":"92","author":"SP Gray","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"JM Forbes","year":"2013","journal-title":"Physiol Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"F Giacco","year":"2010","journal-title":"Circ Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e67813","DOI":"10.1371\/journal.pone.0067813","article-title":"Activation of ErbB2 and Downstream Signaling via Rho Kinases and ERK1\/2 Contributes to Diabetes-Induced Vascular Dysfunction","volume":"8","author":"S Akhtar","year":"2013","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1476-5381.2011.01613.x","article-title":"Angiotensin-(1\u20137) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway","volume":"165","author":"S Akhtar","year":"2012","journal-title":"Br J Pharmacol"},{"key":"ref6","first-page":"5","article-title":"The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction","volume":"3","author":"S Akhtar","year":"2013","journal-title":"BioImpacts"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.bjp.0706238","article-title":"Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed","volume":"145","author":"IF Benter","year":"2005","journal-title":"Br J Pharmacol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000085904","article-title":"Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase","volume":"42","author":"IF Benter","year":"2005","journal-title":"J Vasc Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.vph.2009.06.008","article-title":"Early inhibition of EGFR signaling prevents diabetes-induced up-regulation of multiple gene pathways in the mesenteric vasculature","volume":"51","author":"IF Benter","year":"2009","journal-title":"Vascul Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/HYPERTENSIONAHA.112.192500","article-title":"A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus","volume":"60","author":"M Gal\u00e1n","year":"2012","journal-title":"Hypertension"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/dmrr.1050","article-title":"Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase","volume":"26","author":"K Matrougui","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2013.11.002","article-title":"The ErbB\/HER family of protein-tyrosine kinases and cancer","volume":"79","author":"R Roskoski Jr","year":"2014","journal-title":"Pharmacol Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"F Ciardiello","year":"2008","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2174\/138161282004140213155050","article-title":"Transactivation of ErbB receptors by leptin in the cardiovascular system: mechanisms, consequences and target for therapy","volume":"20","author":"J Be\u0142towski","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/1570161112666140226123745","article-title":"Transactivation of EGFR by G protein-coupled receptor in the pathophysiology of intimal hyperplasia","volume":"12","author":"S Sur","year":"2014","journal-title":"Curr Vasc Pharmacol"},{"issue":"6565","key":"ref16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/379557a0","article-title":"Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors","volume":"379","author":"H Daub","year":"1996","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/CS20060342","article-title":"Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology","volume":"112","author":"S Higuchi","year":"2007","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.mce.2010.04.008","article-title":"EGF receptor activation by GPCRs: an universal pathway reveals different versions","volume":"331","author":"C Liebmann","year":"2011","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1476-5381.2010.00829.x","article-title":"\u03b11-Adrenoceptor-mediated contraction of rat aorta is partly mediated via transactivation of the epidermal growth factor receptor","volume":"161","author":"N Ulu","year":"2010","journal-title":"Br J Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1474-8673.2004.00333.x","article-title":"The role of tyrosine kinase-mediated pathways in diabetes-induced alterations in responsiveness of rat carotid artery","volume":"25","author":"MH Yousif","year":"2005","journal-title":"Auton Autacoid Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: Renin-Angiotensin-aldosterone system alterations","volume":"116","author":"L Te Riet","year":"2015","journal-title":"Circ Res"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1024\/0301-1526\/a000387","article-title":"Counter-regulatory effects played by the ACE\u2014Ang II\u2014AT1 and ACE2\u2014Ang-(1\u20137)\u2014Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications","volume":"43","author":"L Pernomian","year":"2014","journal-title":"Vasa"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/CS20130344","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications","volume":"126","author":"VB Patel","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fendo.2013.00201","article-title":"Update on the Angiotensin converting enzyme 2-Angiotensin (1\u20137)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways","volume":"4","author":"MC Chappell","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/CS20130436","article-title":"Angiotensin-(1\u20137) and angiotensin-(1\u20139): function in cardiac and vascular remodelling","volume":"126","author":"CA McKinney","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0196-9781(93)90097-Z","article-title":"Cardiovascular actions of angiotensin(1\u20137)","volume":"14","author":"IF Benter","year":"1993","journal-title":"Peptides"},{"issue":"1 Pt 2","key":"ref27","first-page":"H313","article-title":"Antihypertensive actions of angiotensin-(1\u20137) in spontaneously hypertensive rats","volume":"269","author":"IF Benter","year":"1995","journal-title":"Am J Physiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"H666","DOI":"10.1152\/ajpheart.00372.2006","article-title":"Angiotensin-(1\u20137) prevents diabetes-induced cardiovascular dysfunction","volume":"292","author":"IF Benter","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"142154","DOI":"10.1155\/2014\/142154","article-title":"Chronic treatment with Ang-(1\u20137) reverses abnormal reactivity in the corpus cavernosum and normalizes diabetes-induced changes in the protein levels of ACE, ACE2, ROCK1, ROCK2 and omega-hydroxylase in a rat model of type 1 diabetes","volume":"2014","author":"MH Yousif","year":"2014","journal-title":"J Diabetes Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/FJC.0b013e31821324b6","article-title":"Angiotensin-(1\u20137) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester","volume":"57","author":"IF Benter","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e39066","DOI":"10.1371\/journal.pone.0039066","article-title":"Activation of EGFR\/ERBB2 via pathways involving ERK1\/2, P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from ischemia-reperfusion injury","volume":"7","author":"S Akhtar","year":"2012","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2337\/db07-0739","article-title":"Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db\/db mice","volume":"57","author":"S Belmadani","year":"2008","journal-title":"Diabetes"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1038\/srep08209","article-title":"Angiotensin-converting enzyme 2\/angiotensin-(1\u20137)\/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK\/NF-\u03baB pathways","volume":"5","author":"Y Li","year":"2015","journal-title":"Sci Rep"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1111\/bph.12770","article-title":"Angiotensin-(1\u20137) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas\/eNOS-dependent pathway","volume":"171","author":"T Jiang","year":"2014","journal-title":"Br J Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.niox.2013.12.007","article-title":"Ang-(1\u20137) activates the NO\/cGMP and ATP-sensitive K+ channels pathway to induce peripheral antinociception in rats","volume":"37","author":"A Costa","year":"2014","journal-title":"Nitric Oxide"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/j.1476-5381.2012.01905.x","article-title":"Angiotensin-(1\u20137) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1\/2- and NF-\u03baB-dependent pathways","volume":"166","author":"AZ El-Hashim","year":"2012","journal-title":"Br J Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.phrs.2008.12.008","article-title":"Endogenous angiotensin-(1\u20137) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats","volume":"59","author":"M Al-Maghrebi","year":"2009","journal-title":"Pharmacol Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","article-title":"Angiotensin-(1\u20137) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways","volume":"49","author":"WO Sampaio","year":"2007","journal-title":"Hypertension"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/boc.201400015","article-title":"Angiotensin-(1\u20137) attenuates angiotensin II-induced signalling associated with activation of a tyrosine phosphatase in Sprague-Dawley rats cardiac fibroblasts","volume":"106","author":"X Tao","year":"2014","journal-title":"Biol Cell"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/jcp.22940","article-title":"Angiotensin-(1\u20137) decreases LPS-induced inflammatory response in macrophages","volume":"227","author":"LL Souza","year":"2012","journal-title":"J Cell Physiol"},{"key":"ref41","article-title":"Renin-Angiotensin System: An Old Player with Novel Functions in Skeletal Muscle","author":"C Cabello-Verrugio","year":"2015","journal-title":"Med Res Rev"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2014.05.024","article-title":"The ACE2\/Ang-(1\u20137)\/Mas axis can inhibit hepatic insulin resistance","volume":"393","author":"X Cao","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/HYPERTENSIONAHA.113.03025","article-title":"Angiotensin-(1\u20137) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor","volume":"63","author":"Z Fu","year":"2014","journal-title":"Hypertension"},{"key":"ref44","article-title":"The challenge of blocking a wider family members of EGFR against head and neck squamous cell carcinomas","author":"J Martinez-Useros","year":"2015","journal-title":"Oral Oncol"},{"key":"ref45","article-title":"Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN)","author":"KA Price","year":"2015","journal-title":"Oral Oncol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fonc.2015.00002","article-title":"The Potential of panHER Inhibition in Cancer","volume":"5","author":"X Wang","year":"2015","journal-title":"Front Oncol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.2174\/0929867321666140205133357","article-title":"Angiotensin-(1\u20137): a peptide hormone with anti-cancer activity","volume":"21","author":"PE Gallagher","year":"2014","journal-title":"Curr Med Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/1061186X.2015.1057150","article-title":"The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes","volume":"23","author":"IF Benter","year":"2015","journal-title":"J Drug Target"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141657","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:16:40Z","timestamp":1588983400000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141657"}},"subtitle":[],"editor":[{"given":"Jean-Claude","family":"Dussaule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141657","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]}}}